Epstein Secrets

irus Task Force," the New York Times (10/8, Mazzetti, Weiland, Stolberg, 18.61M) reports that Vice President Pence's "decision to walk the halls of the Mayo Clinic without a mask" on April 28 is "only one example of how, over nearly eight months since the vice president was given a leading role in managing the

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

irus Task Force," the New York Times (10/8, Mazzetti, Weiland, Stolberg, 18.61M) reports that Vice President Pence's "decision to walk the halls of the Mayo Clinic without a mask" on April 28 is "only one example of how, over nearly eight months since the vice president was given a leading role in EFTA00148804

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "

730 The New York TiMPi (8/4, Thomas, Weiland, 18.61M) reports, "Since April, the Trump administration has funneled $48 million into a program with the Mayo Clinic, allowing more than 53,000 Covid-19 patients to get plasma infusions." However, "the unexpected demand for plasma has inadvertently undercut the re

Lilly Seeking Volunteers For Antibody Drug Trials. On NBC Nightly NewsVi (8/4, story 8, 1:45, 6.1M), Tom Costello reported, "The NIH and drugmaker Eli Lilly are tonight looking for 2,000 volunteers for antibody drug trials to treat patients suffering from the ravages of COVID. One trial involves patients

irus Task Force," the New York Times (10/8, Mazzetti, Weiland, Stolberg, 18.61M) reports that Vice President Pence's "decision to walk the halls of the Mayo Clinic without a mask" on April 28 is "only one example of how, over nearly eight months since the vice president was given a leading role in managing the

touted an experimental antibody treatment as a cure for COVID...two companies who make the treatments applied for emergency authority from the FDA. Eli Lilly and Regeneron say their antibodies made in the lab mimic the way the immune system fights infection." Dahlgren said Regeneron's early trials data "